ERBB2 and breast cancer: In breast cancer several clinical features, such as age, tumor size, axillary lymph node status, hormone and human epidermal growth factor receptor 2 (HER2) receptor status, histological grade or the presence of metastasis are routinely investigated in order to provide the patients with the best treatment [17].